A cutting-edge clinical trial for people with a rare blood cancer is being expanded across Australia and potentially beyond. The study is currently underway at the Royal Adelaide Hospital and the Austin Hospital in Melbourne. Additional sites to be established in New South Wales, Queensland, Victoria, Tasmania. Associate Professor Dan Thomas, the head of the Blood …
Continue reading "Lenzilumab treatment for rare blood cancers are expanding 2023."
GLOBAL RISK FUND 